Wet AMD 3 Symposium

Related

• 

  Sustained Diabetic Retinopathy Severity Improvement With Intravitreal Aflibercept in DME: Post Hoc Analysis of VISTA and VIVID

  Rishi P. Singh, MD

  Annual Meeting Talks

  2019

• 

  Long-term Clinical Impact of Intravitreal anti-VEGF Therapy for Severe Non-proliferative Diabetic Retinopathy (NPDR): Analyses Through a Discrete Event Simulation Model

  Jennifer I. Lim, MD, FARVO, FASRS

  Updates from the Field

  2021

• 

  Suprachoroidal Delivery of RGX-314 for Neovascular AMD: Initial Results From the Phase II  AAVIATE Study

  Mark R. Barakat, MD

  Updates from the Field

  2021